My Bibliography

select

Chen J, Fu Z. [A retrotransposon-like element Tca1 was used for taxonomic determination of Candida albicans]. Wei Sheng Wu Xue Bao. 1996 Jun;36(3):161-7. PubMed PMID: 9639815.

select

Wang Q, Fu Z, Zhou S, Chen JY. [The transcriptional regulation of the TCA1 elements and their effects on morphogenesis of Candida albicans]. Shi Yan Sheng Wu Xue Bao. 1998 Jun;31(2):117-27. PubMed PMID: 12014140.

select

Chen Jy, Wang Q, Fu Z, Zhou S, Fonzi WA. Tca1, the retrotransposon-like element of Candida albicans, is a degenerate and inactive element. J Bacteriol. 1998 Jul;180(14):3657-62. doi: 10.1128/JB.180.14.3657-3662.1998. PubMed PMID: 9658011; PubMed Central PMCID: PMC107336.

select

Fu Z, Cannon MJ. Functional analysis of the CD4(+) T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression. J Virol. 2000 Jul;74(14):6675-9. doi: 10.1128/jvi.74.14.6675-6679.2000. PubMed PMID: 10864684; PubMed Central PMCID: PMC112180.

select

Dai J, Lin D, Zhang J, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET. Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J Clin Invest. 2000 Oct;106(7):887-95. doi: 10.1172/JCI10483. PubMed PMID: 11018077; PubMed Central PMCID: PMC381425.

select

Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, Mizokami A, Fu Z, Westman J, Keller ET. Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest. 2001 May;107(10):1235-44. doi: 10.1172/JCI11685. PubMed PMID: 11375413; PubMed Central PMCID: PMC209296.

select

Fu Z, Dozmorov IM, Keller ET. Osteoblasts produce soluble factors that induce a gene expression pattern in non-metastatic prostate cancer cells, similar to that found in bone metastatic prostate cancer cells. Prostate. 2002 Apr 1;51(1):10-20. doi: 10.1002/pros.10056. PubMed PMID: 11920953.

select

Zhang J, Dai J, Lin DL, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET. Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice. J Bone Miner Res. 2002 Jul;17(7):1256-63. doi: 10.1359/jbmr.2002.17.7.1256. PubMed PMID: 12096839.

select

Khanolkar A, Fu Z, Underwood LJ, Bondurant KL, Rochford R, Cannon MJ. CD4+ T cell-induced differentiation of EBV-transformed lymphoblastoid cells is associated with diminished recognition by EBV-specific CD8+ cytotoxic T cells. J Immunol. 2003 Mar 15;170(6):3187-94. doi: 10.4049/jimmunol.170.6.3187. PubMed PMID: 12626577.

select

Fu Z, Smith PC, Zhang L, Rubin MA, Dunn RL, Yao Z, Keller ET. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J Natl Cancer Inst. 2003 Jun 18;95(12):878-89. doi: 10.1093/jnci/95.12.878. PubMed PMID: 12813171.

select

Keller ET, Fu Z. Defining RKIP as a protein that regulates prostate cancer metastasis. The American Journal of Urology review. 2004; 2(2):72-80.

select

Chatterjee D, Bai Y, Wang Z, Beach S, Mott S, Roy R, Braastad C, Sun Y, Mukhopadhyay A, Aggarwal BB, Darnowski J, Pantazis P, Wyche J, Fu Z, Kitagwa Y, Keller ET, Sedivy JM, Yeung KC. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem. 2004 Apr 23;279(17):17515-23. doi: 10.1074/jbc.M313816200. Epub 2004 Feb 6. PubMed PMID: 14766752.

select

Keller ET, Fu Z, Yeung K, Brennan M. Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene. Cancer Lett. 2004 Apr 30;207(2):131-7. doi: 10.1016/j.canlet.2004.02.006. Review. PubMed PMID: 15151133.

select

Zhang L, Fu Z, Binkley C, Giordano T, Burant CF, Logsdon CD, Simeone DM. Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery. 2004 Sep;136(3):708-15. doi: 10.1016/j.surg.2003.12.013. PubMed PMID: 15349122.

select

Keller ET, Fu Z, Brennan M. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol. 2004 Sep 15;68(6):1049-53. doi: 10.1016/j.bcp.2004.04.024. Review. PubMed PMID: 15313400.

select

Fu Z, Keller ET. Role of immunohistochemical expression of raf kinase inhibitor protein in prostate carcinoma Waltham, Mass, USA: Elsevier Science/Academic Press; 2004. 471-479p.

select

Fu Z, Zhang L, Keller ET. Immunohistochemical expression of raf kinase inhibitor protein in prostate carcinoma. In: Handbook of Immunohistichemistry and In Situ Hybridization of Human Carcinomas [Internet] Waltham, Massachusetts: Elsevier; 2004. Chapter 20; p.471-479. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1874578402800526.

select

Keller ET, Fu Z. Defining RKIP as a protein that regulates prostate cancer metastasis. American Journal of Urology Research. 2004; 2(2):72.

select

Keller ET, Fu Z, Brennan M. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein. J Cell Biochem. 2005 Feb 1;94(2):273-8. doi: 10.1002/jcb.20169. Review. PubMed PMID: 15565643.

select

Fu Z, Kitagawa Y, Shen R, Shah R, Mehra R, Rhodes D, Keller PJ, Mizokami A, Dunn R, Chinnaiyan AM, Yao Z, Keller ET. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate. 2006 Feb 15;66(3):248-56. doi: 10.1002/pros.20319. PubMed PMID: 16175585.

select

Fu Z, Tindall DJ. FOXOs, cancer and regulation of apoptosis. Oncogene. 2008 Apr 7;27(16):2312-9. doi: 10.1038/onc.2008.24. Review. PubMed PMID: 18391973; PubMed Central PMCID: PMC2819403.

select

Fu Z, Malureanu L, Huang J, Wang W, Li H, van Deursen JM, Tindall DJ, Chen J. Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression. Nat Cell Biol. 2008 Sep;10(9):1076-82. doi: 10.1038/ncb1767. PubMed PMID: 19160488; PubMed Central PMCID: PMC2882053.

select

Fu Z, Regan K, Zhang L, Muders MH, Thibodeau SN, French A, Wu Y, Kaufmann SH, Lingle WL, Chen J, Tindall DJ. Deficiencies in Chfr and Mlh1 synergistically enhance tumor susceptibility in mice. J Clin Invest. 2009 Sep;119(9):2714-24. doi: 10.1172/JCI37405. Epub 2009 Aug 17. PubMed PMID: 19690386; PubMed Central PMCID: PMC2735912.

select

Zhang H, Wu J, Keller JM, Yeung K, Keller ET, Fu Z. Transcriptional regulation of RKIP expression by androgen in prostate cells. Cell Physiol Biochem. 2012;30(6):1340-50. doi: 10.1159/000343323. Epub 2012 Oct 23. PubMed PMID: 23095933.

select

Yuan C, Wang L, Zhou L, Fu Z. The function of FOXO1 in the late phases of the cell cycle is suppressed by PLK1-mediated phosphorylation. Cell Cycle. 2014;13(5):807-19. doi: 10.4161/cc.27727. Epub 2014 Jan 9. PubMed PMID: 24407358; PubMed Central PMCID: PMC3979917.

select

Zhang J, Yuan C, Wu J, Elsayed Z, Fu Z. Polo-like kinase 1-mediated phosphorylation of Forkhead box protein M1b antagonizes its SUMOylation and facilitates its mitotic function. J Biol Chem. 2015 Feb 6;290(6):3708-19. doi: 10.1074/jbc.M114.634386. Epub 2014 Dec 22. PubMed PMID: 25533473; PubMed Central PMCID: PMC4319035.

select

Wu J, Ivanov AI, Fisher PB, Fu Z. Polo-like kinase 1 induces epithelial-to-mesenchymal transition and promotes epithelial cell motility by activating CRAF/ERK signaling. Elife. 2016 Mar 22;5. doi: 10.7554/eLife.10734. PubMed PMID: 27003818; PubMed Central PMCID: PMC4811775.

select

Fu Z, Wen D. The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis. Cancers (Basel). 2017 Sep 27;9(10). doi: 10.3390/cancers9100131. Review. PubMed PMID: 28953239; PubMed Central PMCID: PMC5664070.

select

Wen D, Wu J, Wang L, Fu Z. SUMOylation Promotes Nuclear Import and Stabilization of Polo-like Kinase 1 to Support Its Mitotic Function. Cell Rep. 2017 Nov 21;21(8):2147-2159. doi: 10.1016/j.celrep.2017.10.085. PubMed PMID: 29166606; PubMed Central PMCID: PMC5728694.

select

Gheghiani L, Shang S, Fu Z. Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer. Sci Rep. 2020 Jul 23;10(1):12327. doi: 10.1038/s41598-020-69338-8. PubMed PMID: 32704044; PubMed Central PMCID: PMC7378169.

select

Gheghiani L, Wang L, Zhang Y, Moore XTR, Zhang J, Smith SC, Tian Y, Wang L, Turner K, Jackson-Cook CK, Mukhopadhyay ND, Fu Z. PLK1 Induces Chromosomal Instability and Overrides Cell-Cycle Checkpoints to Drive Tumorigenesis. Cancer Res. 2021 Mar 1;81(5):1293-1307. doi: 10.1158/0008-5472.CAN-20-1377. Epub 2020 Dec 29. PubMed PMID: 33376114; PubMed Central PMCID: PMC8026515.

select

Moore XTR, Gheghiani L, Fu Z. The Role of Polo-Like Kinase 1 in Regulating the Forkhead Box Family Transcription Factors. Cells. 2023 May 8;12(9). doi: 10.3390/cells12091344. Review. PubMed PMID: 37174744; PubMed Central PMCID: PMC10177174.

select

Gheghiani L, Fu Z. The dark side of PLK1: Implications for cancer and genomic instability. Oncotarget. 2023 Jun 27;14:657-659. doi: 10.18632/oncotarget.28456. PubMed PMID: 37367493; PubMed Central PMCID: PMC10295679.

select

Calbay O, Padia R, Akter M, Sun L, Li B, Qian N, Guo J, Fu Z, Jin L, Huang S. ASC/inflammasome-independent pyroptosis in ovarian cancer cells through translational augmentation of caspase-1. iScience. 2023 Dec 15;26(12):108408. doi: 10.1016/j.isci.2023.108408. eCollection 2023 Dec 15. PubMed PMID: 38058301; PubMed Central PMCID: PMC10696124.

select

Hawsawi O, Xue W, Du T, Guo M, Yu X, Zhang M, Hoffman PS, Bollag R, Li J, Zhou J, Wang H, Zhang J, Fu Z, Chen X, Yan C. Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growth. Cell Rep Med. 2025 Jan 21;6(1):101890. doi: 10.1016/j.xcrm.2024.101890. Epub 2025 Jan 9. PubMed PMID: 39793570; PubMed Central PMCID: PMC11866447.

select

Padia R, Sun L, Liao YF, Calbay O, Chi C, Akter M, Wu L, Fu Z, Zhang DD, Huang S. HOXC8 impacts lung tumorigenesis by preventing pyroptotic cell death through the suppression of caspase-1 expression. Cell Death Dis. 2025 Jul 23;16(1):552. doi: 10.1038/s41419-025-07867-8. PubMed PMID: 40701951; PubMed Central PMCID: PMC12287344.